The University of Oxford has become the first UK academic institution to receive support from the European Medicines Agency's (EMA) PRIority MEdicines (PRIME) scheme for its vaccine targeting the deadly Nipah virus.
South Korea's leading molecular diagnostics (MDx) company Seegene Inc. has developed a PCR to detect positive cases of monkeypox virus within 90 minutes.
Peter Bretscher, from the University of Saskatchewan looks at whether mouse models of cutaneous leishmaniasis are pertinent for vaccination against and treatment of AIDS, infectious diseases, and cancer.
Will Wepsala, Public Affairs Specialist at the Animal and Plant Health Inspection Service, part of the U.S. Department of Agriculture, walks us through the work of intercepting smuggled products to protect animal health.
Empowering employees and examining emerging health threats in a new strategy for business growth is Novacyt CEO David Allmond’s mission in the weeks ahead.
This ‘unusual’ monkeypox outbreak has been found to be larger and more widespread than previous outbreaks outside of Africa, and health experts propose better preparation.
The World Health Organisation (WHO) say the pandemic led to 14.9 million global excess deaths, caused either by the virus itself or disrupted access to healthcare.
A geoengineering strategy to inject aerosols into the stratosphere could have repercussions, with the potential worsening of a tropical malaria outbreak.
By analysing patient samples, researchers believe they now understand how the human immune system protects the body from malaria - opening the door to new malaria treatments.
